Next Century Growth Investors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,909
Closed -$1.94M 126
2022
Q3
$1.94M Buy
7,909
+3,668
+86% +$991K 0.24% 75
2022
Q2
$1.05M Buy
+4,241
New +$1.14M 0.14% 96
2019
Q3
Sell
-4,211
Closed -$1.1M 140
2019
Q2
$1.1M Buy
4,211
+619
+17% +$164K 0.14% 115
2019
Q1
$1.02M Hold
3,592
0.14% 115
2018
Q4
$1.17M Buy
3,592
+85
+2% +$29.5K 0.17% 111
2018
Q3
$1.58M Sell
3,507
-102
-3% -$40.2K 0.18% 119
2018
Q2
$1.48M Sell
3,609
-50,399
-93% -$18.3M 0.19% 118
2018
Q1
$15.7M Sell
54,008
-30,978
-36% -$7.85M 2.1% 7
2017
Q4
$15.9M Sell
84,986
-20,778
-20% -$3.88M 1.98% 14
2017
Q3
$17.8M Sell
105,764
-37,097
-26% -$5.61M 2.14% 8
2017
Q2
$20.5M Sell
142,861
-49,092
-26% -$6.6M 1.96% 8
2017
Q1
$24M Sell
191,953
-205,097
-52% -$23.8M 2.04% 6
2016
Q4
$44.7M Sell
397,050
-26,340
-6% -$3.05M 2.74% 4
2016
Q3
$54.4M Sell
423,390
-33,550
-7% -$4.02M 2.5% 4
2016
Q2
$49.9M Sell
456,940
-154,351
-25% -$15.4M 2.33% 8
2016
Q1
$58M Buy
611,291
+2,766
+0.5% +$233K 2.73% 2
2015
Q4
$54.9M Buy
608,525
+19,885
+3% +$1.69M 2.37% 4
2015
Q3
$54.6M Sell
588,640
-178,831
-23% -$15.8M 2.27% 6
2015
Q2
$50.4M Buy
767,471
+116,472
+18% +$7.74M 1.74% 10
2015
Q1
$46.6M Sell
650,999
-379,179
-37% -$20.6M 1.64% 10
2014
Q4
$39.2M Sell
1,030,178
-144,020
-12% -$4.54M 1.41% 18
2014
Q3
$29.2M Sell
1,174,198
-521,139
-31% -$13.2M 1.03% 35
2014
Q2
$42.6M Sell
1,695,337
-66,244
-4% -$1.54M 1.37% 20
2014
Q1
$45.9M Sell
1,761,581
-113,687
-6% -$3.15M 1.36% 20
2013
Q4
$50.1M Sell
1,875,268
-112,679
-6% -$2.78M 1.39% 16
2013
Q3
$37.9M Sell
1,987,947
-37,333
-2% -$853K 1.09% 29
2013
Q2
$43.7M Buy
+2,025,280
New +$40.7M 1.4% 22

Other funds holding ABMD

Next Century Growth Investors's ABMD Position: Q4 2022 in Review

Next Century Growth Investors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 7,909 shares — an estimated $1.94M sold.

Next Century Growth Investors first reported a position in ABMD in Q2 2013 and held it in 27 quarters. The position peaked at $58M in Q1 2016. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Next Century Growth Investors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Next Century Growth Investors sold 7,909 Abiomed Inc shares in Q4 2022, an estimated $1.94M.
  • Next Century Growth Investors first reported a position in Abiomed Inc in Q2 2013 and held it in 27 quarters.
  • Next Century Growth Investors's Abiomed Inc position peaked at $58M in Q1 2016.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Next Century Growth Investors's 13F filing for Q4 2022, filed 14 Feb 2023.